Alacris Theranostics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 1

Alacris Theranostics General Information

Description

Developer of cancer treatment strategies. The company offers its therapy guidance to cancer clinics and intends to make technology directly available to patients in the future.

Contact Information

Website
www.alacris.de
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Fabeckstrasse 60-62
  • 14195 Berlin
  • Germany
+49 030 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alacris Theranostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alacris Theranostics‘s full profile, request access.

Request a free trial

Alacris Theranostics Patents

  • 28

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Alacris Theranostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3296905-A1 Method for identifying new markers Pending 15-Sep-2016 000000000
US-20160355878-A1 Method for generating of oligonucleotide arrays using in situ block synthesis approach Abandoned 16-Dec-2013 0000000000 0
EP-3083984-A1 Method for generating of oligonucleotide arrays using in situ block synthesis approach Withdrawn 16-Dec-2013 0000000000
EP-2883963-A1 Method for generating of oligonucleotide arrays using in situ block synthesis approach Withdrawn 16-Dec-2013 0000000000 0
EP-3055801-A1 Computational approach for identifying a combination of two drugs Withdrawn 08-Oct-2013 G16C20/30
To view Alacris Theranostics’s complete patent history, request access »

Alacris Theranostics Executive Team (3)

Name Title Board Seat Contact Info
B. Lange Chief Executive Officer
Alexander Kuhn Associate
You’re viewing 2 of 3 executive team members. Get the full list »

Alacris Theranostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alacris Theranostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alacris Theranostics‘s full profile, request access.

Request a free trial